PAMELA SHAW-GRANT: Open Payments
NPI 1477546489 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,846 in 90 payments from 15 companies in 2025. Trend: 2023 $1,971 · 2024 $2,074 · 2025 $2,846
Food & beverage: $2,846
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 24 | $462 |
| Neurocrine BioSciences, Inc. | 12 | $364 |
| Alkermes, Inc. | 9 | $283 |
| E.R. Squibb & Sons, L.L.C. | 8 | $274 |
| ABBVIE INC. | 9 | $266 |
| Teva Pharmaceuticals USA, Inc. | 8 | $223 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $203 |
| SANOFI-AVENTIS U.S. LLC | 2 | $201 |
| Abbott Laboratories | 2 | $143 |
| Axsome Therapeutics, Inc. | 1 | $124 |
Products named: FANAPT, INGREZZA, COBENFY, VRAYLAR, AUSTEDO XR, TZIELD, ARISTADA, FREESTYLE LIBRE 3.
Industry payments across GA — which companies pay providers there.
